Chargepoint’s senior product manager Ben Wylie explains why single-use technology might be key for complex manufacturing environments.
Complex environment
With the growing demand for medicines that have complex manufacturing requirements, pharmaceutical companies must introduce aseptic and high potency manufacturing processes into their operations. Effective containment during high potency manufacturing is important to protect the safety of operators, while aseptic processing measures must protect the drug product from contamination. Any contamination during the manufacturing process can have a substantial financial impact, not to mention possible implications within the supply chain.
In response, pharmaceutical manufacturing environments are evolving with new technologies, including SMART monitoring capabilities which give manufacturers an automatic / reliable method of understanding the health status of process and transfer devices to better control risk and ensure consistent integrity throughout the life-cycle of the system and its critical components.